• Lab Location: 2817 Miller Ranch Road, Unit 317, Pearland, TX 77584
  • Mailing Address: 600 Jefferson Street, Suite 301, Lafayette, LA 70501
  • Phone: 281-240-0974 Fax: 844-604-0145
RPP.image02.jpg

Respiratory Pathogen Panel Testing

  • Respiratory tract infections are a serious and growing threat –
  • • 30 million cases of influenza are reported annually, resulting in 14.5 million medical visits and more than 600,000 hospitalizations annually
  • • Last year more than 80,000 people died from influenza and related complications
  • • Rapid flu test has a 30% false negative rate during peak flu season
  • • Last year the flu vaccine was only 36% effective overall and 25% effective for the more serious influenza A (H3N2)
  • • 500 million non-influenza upper respiratory tract infections annually
  • • 90% of respiratory tract infections are viral yet the majority of patients are prescribed antibiotics which provide no benefits but have significant side effects
  • Using rPCR (Real Time Polymerase Chain Reaction) we are able to test for a panel of 17 viral and 4 bacterial respiratory tract infections in less than an hour. The benefits to patients and to the community are significant –
  • • Highly accurate testing (97.1% Sensitivity, 99.3% Specificity)
  • • Results delivered within 24-hours so providers can practice evidence based medicine
  • • Significant increase in antibiotic and antiviral stewardship
  • • Reduced ICU stay and hospitalization yield measurable costs savings
  • • Lower potential for secondary infections

Pathogens Tested

  • 17 VIRUSES
  • • Adenovirus (2.5%)*
  • • Coronavirus HKU1 (10.8%)
  • • Coronavirus NL63
  • • Coronavirus 229E
  • • Coronavirus OC43
  • • Human Metapneumovirus (5.4%)
  • • Human Rhinovirus/Enterovirus (7.4%)
  • • Influenza A (13.8%)
  • • Influenza A/H1
  • • Influenza A/ H3
  • • Influenza A/H1-2009
  • • Influenza B (3.7%)
  • • Parainfluenza Virus 1 (1.1%)
  • • Parainfluenza Virus 2
  • • Parainfluenza Virus 3
  • • Parainfluenza Virus 4
  • • Respiratory Syncytial Virus (12.1%)
  • 4 BACTERIA (0.4%)
  • • Bortedella pertussis
  • • Bortedella parapertussis
  • • Chlamydia pneumoniae
  • • Mycoplasma pneumoniae
  • *Percentages are based on BioFire data for January 15, 2018 for
  • the prevalence of respiratory virus groups.
  • https://syndromictrends.com/metric/panel/respiratory/percent_
  • positivity/organism/main